Telmisartan May Not Be Inferior to Enalapril for ...

"The angiotensin II-receptor blocker (ARB) telmisartan is not inferior to the angiotensin-converting-enzyme (ACE) inhibitor enalapril for renoprotection in type 2 diabetes, according to the results of a randomized, multicenter, five-year trial published in the Nov. 4 issue of the New England Journal of Medicine."